Navigation Links
PrimeraDx Appoints Leroy Hood to its Scientific Advisory Board
Date:12/6/2011

MANSFIELD, Mass., Dec. 6, 2011 /PRNewswire/ -- PrimeraDx today announced that Leroy Hood, MD, PhD, a world recognized leader in the molecular device industry, has been appointed to its Scientific Advisory Board. 

"High multiplex qPCR diagnostics is a key step in bringing personalized medicine to the clinic," commented Dr. Hood.  "I am delighted to help PrimeraDx take the step from an innovative next generation qPCR platform to a robust molecular diagnostics solution."

"Lee brings a breadth of knowledge in the molecular device industry that no one else has.  With Lee's scientific vision we will move forward with our goal of transforming molecular diagnostic medicine and improving patient care," said President and CEO Matthew McManus.

Dr. Hood has established a systems approach to understanding the complexity of biology and medicine.  He has played a pivotal role in the DNA sequencing industry and his innovations were essential for the sequencing of the human genome.  Dr. Hood has been instrumental in the founding of numerous research and commercial enterprises, including Applied Biosystems, Amgen and the Institute for System Biology, where he currently holds the position of President.  He has won several awards and accolades, including; the 2003 AMP award for excellence in Molecular Diagnostics, the Academy of Engineering's Russ Prize, the Lasker Award and the Kyoto Prize.  Dr. Hood has more than 700 peer reviewed articles and is a member of the National Academy of Sciences, the National Academy of Engineering and the Institute of Medicine.

About PrimeraDx

PrimeraDx is a molecular diagnostics company that has developed, and is commercializing, a novel, game-changing clinical platform which combines PCR with capillary electrophoresis.  The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative answers to the clinic.  The company is pursuing a two pronged strategy to sell the system in an Open Platform Mode to clinical labs and to collaborate with pharmaceutical companies to develop high-value companion and enabling diagnostic products.  Users can easily design very complex multi-modal assays that test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes.  PrimeraDx's technology represents the next generation of quantitative PCR.  The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysia Technology Development Corporation.  The Company's website is: www.primeradx.com or www.multiplexpcr.com.

CONTACT: Andrew Bond, +1-508-618-2752, abond@primeradx.com


'/>"/>
SOURCE PrimeraDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PrimeraDx Appoints David Heffelfinger as VP of Engineering and Systems Development
2. PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA
3. Ulthera Appoints Greg Waller as Chief Financial Officer
4. Tengion Appoints John L. Miclot President and Chief Executive Officer
5. Remedi SeniorCare® Appoints Corey Gauff SVP of Sales and Account Management
6. Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
7. CVS Caremark Appoints Kevin Murphy President of Accordant Business
8. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
9. Adeona Appoints Jeff Lucero Riley as Independent Chairman
10. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
11. InterMune Appoints Angus C. Russell to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... , April 19, 2017 Global Surgical Drainage ... are tubes used to remove excess liquid and air. ... pus, urine, bile or lymph. Surgical drains are used ... such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery ... post-surgery to prevent accumulation of fluid e.g. blood or ...
Breaking Medicine Technology:
(Date:4/30/2017)... Viejo, CA (PRWEB) , ... April 30, 2017 ... ... animations created exclusively for use in Final Cut Pro X. Editors can pick ... and more. Easily change the highlights, mid levels and shadows using simple color ...
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of ... video to the next without having to set a single keyframe in Final ... enhance your video production. , TransDark features dynamic transitions that momentarily splits the RGB ...
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty ... pounds with the help of a weight loss surgery. The woman, declaring “I will not ... have been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces ... an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start ... 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and maintenance ...
Breaking Medicine News(10 mins):